2025 LCRF | Boehringer Ingelheim Team Science Award on Innovative Therapeutic Strategies to Understand and Treat Lung Cancers Harboring HER2 Mutations
| קרן | Lung Cancer Research Foundation |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 30/09/2025 |
| פקולטה | Life Sciences, Medicine, Social Sciences |
| תיאור | This grant mechanism will focus on the science behind HER2 mutations as oncogenic drivers of malignancy and/or the development of novel therapeutic approaches for patients with tumors harboring HER2 mutations. Funding: $300,000
Research Authority deadline: 21.9.25 LOI (required) due date: 30.9.25 Full proposal due date: 6.1.26 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 02/09/2025 |
